Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.


Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research


Current News

ICR Spring Ethics & GCP Forum

By ICR Secretariat / 07/02/2023 10:26 AM

We are delighted to announce our Spring Ethics & GCP Forum Friday 31st March 2023, at the Cruciform Building, University College London.

The agend…

Trial blazing

By ICR Secretariat / 07/02/2023 09:47 AM

A look at the latest progress in digitised clinical trials suggests that decentralisation does deliver

There has been significant progress in decentra…

AstraZeneca targets the 9 out of 10 people who don't know they have CKD in new TV spot

By ICR Secretariat / 07/02/2023 09:45 AM

AstraZeneca’s latest DTC spot “We Are Targets” for its chronic kidney disease (CKD) med Farxiga is aimed squarely at the nine in 10 adults who have CK…

Gilead’s CAR T-cell therapy recommended for use across the NHS

By ICR Secretariat / 07/02/2023 09:43 AM

Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma

Gilead Sciences has announced that the National Institute …

Sanofi launches new scholarship program to boost diversity in healthcare

By ICR Secretariat / 30/01/2023 10:14 AM

Citing the “trust gap” as one of the greatest challenges in global health today, Sanofi announced its new NextGen Scholarship program, a global initia…

First patients enrolled for Priothera’s mocravimod trial

By ICR Secretariat / 30/01/2023 10:13 AM

Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia

Ipsen's Onivyde proves its worth in aggressive pancreatic cancer

By ICR Secretariat / 30/01/2023 10:11 AM

Ipsen, which is “not at all afraid" to challenge Big Pharma, according to CEO David Loew, is touting a win for its oncology pipeline.

10 clinical trials to watch in the first half of 2023

By ICR Secretariat / 19/01/2023 03:56 PM

The biotechnology industry begins 2023 at a crossroads.

In many ways, the sector is coming off of one of its toughest years in recent memory. Initial …

'The Top Line': FDA's stance on cancer drug approval, plus this week's headlines

By ICR Secretariat / 19/01/2023 03:55 PM

The FDA is making some changes in the accelerated approval process. In this episode, we’ll discuss the recent changes with the FDA’s regulation of can…

5 questions facing gene therapy in 2023

By ICR Secretariat / 19/01/2023 03:53 PM

Sometime before the end of March, a person with the inherited blood disease beta thalassemia will receive an infusion containing hundreds of millions …

Sanofi moves into swanky new Paris HQ designed around hybrid work and sustainability

By ICR Secretariat / 12/12/2022 04:03 PM

As the corporate world evolves in the wake of COVID-19, Sanofi has christened an innovative headquarters to help keep pace.

Course Postponements Due to Covid

By ICR Secretariat / 10/02/2022 03:38 PM

All of our delegates and members who had course places postponed over the last two years due to covid restrictions/illness have now been contacted dir…

Events and Courses

The ICR Ethics & GCP Forum EGCP

Online payments currently temporarily suspended. To make a payment please contact&nbsp;<a href="http://office@icr-global.org/" style="background-...

GCP for Experts M12

THIS COURSE DATE IS TO BE CONFIRMED&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp...

ISO14155: 2020 Clinical investigation of medical devices for human subjects -- Good Clinical Practice M7

Approximately 1.5 million different medical devices are available globally; with thousands of new and innovative medical devices being introduced...

The Essentials of Trial Master File (TMF) Management M4

Online payments currently temporarily suspended. To make a payment please contact&nbsp;<a href="http://office@icr-global.org/" style="backgroun...

The Proactive Clinical Researcher M15

Do you want to work SMARTER not HARDER? &nbsp;This course is focused on the needs of a clinical researcher and is a very practical...

Statistics for Non-Statisticians M13

Statistics is the art and science of summarising data. &nbsp;Statistics play an essential role in all stages of clinical research ...

Current Jobs